JULY 2024LIFE SCIENCES REVIEW4LAST WORDAndreas Søderman, Head of Medical Affairs, OrifarmThe Untapped Potential of Medical Affairs in Generics, Value added medicines and Hybrid pharmaceuticals30Dr. Linda Randall, AVP, Biologics Development, Manufacturing & Control, PharmaronThe Tipping Point for Scalable Manufacturing Processes to Pivot Gene Therapies08CONTENTS12COVER STORYIN MY OPINIONMICHIEL JANNINK,CEOUPSCALING CELL CULTIVATION PROCESS WITH AUTOMATED SOLUTIONSCINUS Cell Expansion
< Page 3 | Page 5 >